Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding two more conditions and noting that the study now includes 19 locations, while the previous version 2.9.7 has been removed.
    Difference
    0.4%
    Check dated 2024-07-23T14:27:35.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:39:13.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:17:56.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:58:06.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:44:12.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less Genetic and Rare Diseases Information Center resources: Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Chromophil Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma Drug Information available for: Ipilimumab Nivolumab FDA Drug and Device Resources Show less'. This change represents an update in the information provided on the webpage regarding genetic and rare diseases information center resources related to renal cell carcinoma and available drug information for Ipilimumab and Nivolumab.
    Difference
    31%
    Check dated 2024-06-25T08:27:33.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.